CJ Bioscience, Inc. (KOSDAQ:A311690) agreed to acquire Red BIO business of CJ Cheiljedang Corporation (KOSE:A097950) for KRW 6.1 billion on November 8, 2021. The transaction is expected to close on January 3, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,970 KRW | +0.36% | +0.36% | -13.44% |
1st Jan change | Capi. | |
---|---|---|
-13.44% | 93.26M | |
+41.05% | 54.04B | |
+43.57% | 41.96B | |
-1.16% | 41.92B | |
-7.59% | 28.35B | |
+12.49% | 26.35B | |
-22.11% | 19B | |
+7.76% | 13B | |
+28.48% | 12.28B | |
+24.89% | 12.19B |
- Stock Market
- Equities
- A311690 Stock
- News CJ Bioscience, Inc.
- CJ Bioscience, Inc. agreed to acquire Red BIO business of CJ Cheiljedang Corporation for KRW 6.1 billion.